Temenos (TEMN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
24 Feb, 2026Executive summary
Achieved all 2025 guidance metrics, with product revenue constant currency growth of 11%, outpacing market growth of 7%.
Strong demand across regions and client tiers, with multiple Tier 1 bank wins in the US and Japan, and robust maintenance growth.
Significant investments in sales and product, increasing sales quota carrier headcount by 60% to over 140, and executing on AI strategy.
FY-26 guidance announced and FY-28 targets raised, reflecting confidence in strategic positioning and strong execution.
Sale of Multifonds completed in Q2-25; all figures proforma exclude Multifonds.
Financial highlights
ARR grew 12% year-on-year in Q4 2025, reaching $860 million, now over 90% of product revenue.
Product revenue up 11% to $943m; total revenue up 10% to $1,071m (non-IFRS, constant currency, proforma).
Subscription and SaaS revenue up 9% to $453m; maintenance revenue up 17%.
Non-IFRS EBIT up 22% to $372m; non-IFRS EPS up 25% to $4.20.
Free cash flow up 15% to $256m.
Outlook and guidance
2026 guidance: ~12% ARR growth, ~9% subscription and SaaS growth, ~9% EBIT growth, ~7% EPS growth, ~16% free cash flow growth.
No further headwind from BNPL client termination beyond 2026.
2028 targets raised: ARR above $1.23 billion, EBIT ~$480 million, free cash flow ~$410 million.
Latest events from Temenos
- Upgraded 2028 targets: ARR above $1.23B, recurring revenue, and strong AI-driven U.S. growth.TEMN
CMD 202625 Feb 2026 - Q2-24 saw 12% ARR growth, 8% higher EPS, and revised FY-24 guidance after sales delays.TEMN
Q2 20243 Feb 2026 - Q2-25 delivered strong growth in revenue, profit, and ARR, prompting a raised FY-25 outlook.TEMN
Q2 202520 Jan 2026 - Q1-25 saw strong ARR, EBIT, and cash flow growth, with FY-25 guidance and CHF 250m buyback confirmed.TEMN
Q1 202520 Jan 2026 - Q3 2025 delivered double-digit growth, raised guidance, and completed a major share buyback.TEMN
Q3 202520 Jan 2026 - Q3-24 saw strong profit growth and a major share buyback, but ARR and FCF guidance was trimmed.TEMN
Q3 202419 Jan 2026 - FY-28 targets: ARR > $1.3bn, EBIT $500m, FCF $420m, driven by US and modular growth focus.TEMN
CMD 202415 Jan 2026 - Q4-24 and FY-24 saw robust ARR and cash flow growth, with a strong outlook post-Multifonds sale.TEMN
Q4 202416 Dec 2025